EMA/PE/0000182808 - paediatric investigation plan

zoliflodacin

Key facts

• Active substance:
  zoliflodacin
• Therapeutic area:
  Infections and infestations
• Decision number:
  P/0381/2022
• PIP number:
  EMA/PE/0000182808
• Pharmaceutical form(s):
  Granules for oral suspension
• Condition(s) / indication(s):
  Treatment of gonococcal infection
• Route(s) of administration:
  Oral use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  06/12/2024
• Compliance check done:
  No

Decision

EMA/PE/0000182808 : EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for zoliflodacin

Adopted